Pulmonx
LUNG
111 hedge funds and large institutions have $220M invested in Pulmonx in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 27 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 31
0.46% less ownership
Funds ownership: 89.97% → 89.5% (-0.46%)
6% less funds holding
Funds holding: 118 → 111 (-7)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
31% less capital invested
Capital invested by funds: $321M → $220M (-$101M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.94M |
| 3 |
JP Morgan Chase
New York
|
+$5.89M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.28M |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19M |
| 2 |
BlackRock
New York
|
-$2.84M |
| 3 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$1.93M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.89M |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$1.78M |
LUNG Hedge Fund Activity: Q2 2024 in Review
111 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q2 2024, worth a combined $220M — down 31% from $321M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of LUNG and 21 opened new positions — a net loss of 6 holders — while 31 trimmed existing stakes and 40 added.
The largest buyer was Morgan Stanley, adding an estimated $6.3M. The largest seller was Point72 Asset Management, cutting an estimated $19M.
- 111 institutional investors held Pulmonx (LUNG) as of Q2 2024, down from 118 in Q1 2024.
- Funds reported $220M of Pulmonx stock for Q2 2024, down 31% quarter-over-quarter.
- 21 funds opened new Pulmonx positions in Q2 2024 and 27 closed out, a net change of -6 holders.
- The largest Pulmonx buyer in Q2 2024 was Morgan Stanley, an estimated $6.3M added.
- The largest Pulmonx seller in Q2 2024 was Point72 Asset Management, an estimated $19M sold.
Based on aggregated 13F filings for Q2 2024.